Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors

NCT: NCT06421987 · RECRUITING

NCT IDNCT06421987
StatusRECRUITING
Start Date2024-05-06
Completion2027-12

Brief Summary

SURVIVORS Study participants are being asked to take part in this research study called HODNIRS because the participant is a survivor of Hodgkin Lymphoma (HL) treated with chest radiation and bleomycin at St. Jude Children's Research Hospital. The study is being done to help investigators understand the link between long term effects of chest radiation and bleomycin for HL and brain function in survivors. Primary Objective To evaluate dynamic changes in CBF and oxygenation during exercise with Near Infrared Spectroscopy (NIRS) in HL survivors and non-cancer controls matched for age, sex, race, and ethnicity. . Secondary Objectives To examine the degree of CO2 clearance (DLCO/ETCO2) during rest and exercise in Hodgkin Lymphoma (HL) survivors compared to non-cancer controls matched for age, sex, race, and ethnicity. CONTROLS Volunteers are being asked to take part in this research study because they are non-first degree relative or friend of someone who received treatment for a childhood cancer or similar illness at St. Jude Children's Research Hospital or are an employee/affiliate of St. Jude Children's Research Hospital and have agreed to be a St. Jude Life Cohort Study (SJLIFE) community control.

Frequently Asked Questions

What is Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors?

Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors is a clinical trial registered under NCT06421987. Current status: RECRUITING.

What is the status of NCT06421987?

The current status of NCT06421987 (Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors) is: RECRUITING.

When did Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors start?

Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors started on 2024-05-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.